ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,424,309 | -12.0% | 163,018 | -0.3% | 0.02% | -4.8% |
| Q2 2023 | $5,025,898 | -18.8% | 163,497 | -4.8% | 0.02% | -25.0% |
| Q1 2023 | $6,190,242 | +17.0% | 171,808 | +28.4% | 0.03% | +7.7% |
| Q4 2022 | $5,290,781 | -5.0% | 133,811 | -3.5% | 0.03% | -7.1% |
| Q3 2022 | $5,571,000 | -0.4% | 138,670 | +4.2% | 0.03% | +7.7% |
| Q2 2022 | $5,593,000 | +5.4% | 133,042 | -2.3% | 0.03% | +23.8% |
| Q1 2022 | $5,304,000 | -7.4% | 136,141 | -5.0% | 0.02% | +5.0% |
| Q4 2021 | $5,726,000 | +117.2% | 143,361 | +96.5% | 0.02% | +100.0% |
| Q3 2021 | $2,636,000 | -17.3% | 72,953 | -6.2% | 0.01% | -16.7% |
| Q2 2021 | $3,187,000 | -9.4% | 77,751 | -3.6% | 0.01% | -14.3% |
| Q1 2021 | $3,519,000 | +27.6% | 80,686 | +45.1% | 0.01% | +27.3% |
| Q4 2020 | $2,758,000 | – | 55,619 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |